
Does A Private Sale Trigger The ‘On-Sale Bar’ For Patents?
From oral arguments in this case, it’s not clear how the Supreme Court will ultimately decide.
From oral arguments in this case, it’s not clear how the Supreme Court will ultimately decide.
How will SCOTUS address the issue? That is anything but certain.
Share your insights in this brief survey.
Why should a government agency not be able to correct its own mistakes?
The Federal Circuit will continue in its efforts to bring uniformity to patent law, and will not shy away from challenges presented by the America Invents Act.
Here are three big reasons why, according to IP columnist Tom Kulik.
If this tactic is allowed, it will be a big win for Big Pharma -- and a big loss for patients and consumers.
Discover five practical ways to harness AI and eliminate busywork—so you can focus more on your clients and less on repetitive tasks.
This Biglaw partner brings pharma experience to law firm cases.
Is the field of IP litigation still worth getting into?